Page last updated: 2024-08-24

cidofovir anhydrous and Multiple Myeloma

cidofovir anhydrous has been researched along with Multiple Myeloma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feltkamp, MC; Fouchier, RA; Hajdarbegovic, E; Jones, T; Muhlemann, B; van Boheemen, S1
Brustia, D; Cantello, R; Comi, C; Conconi, A; De Paoli, L; Gaidano, G; Monaco, F; Mula, M; Nasuelli, N; Ripellino, P; Savio, K; Stecco, A; Varrasi, C1
Kaul, DR; Nicolasora, NP; Reddy, P1

Other Studies

3 other study(ies) available for cidofovir anhydrous and Multiple Myeloma

ArticleYear
Cidofovir gel as treatment of follicular spicules in multiple myeloma.
    JAMA dermatology, 2015, Volume: 151, Issue:1

    Topics: Aged; Antiviral Agents; Carcinoma, Merkel Cell; Cidofovir; Cytosine; Gels; Hair Follicle; Humans; Male; Merkel cell polyomavirus; Multiple Myeloma; Organophosphonates; Polyomavirus Infections; Skin Neoplasms

2015
Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option.
    BMJ case reports, 2011, Apr-15, Volume: 2011

    Topics: Antidepressive Agents, Tricyclic; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Mianserin; Middle Aged; Mirtazapine; Multiple Myeloma; Organophosphonates; Postoperative Complications; Transplantation, Autologous

2011
Biopsy-proven adenoviral diarrhea responding to low-dose cidofovir.
    Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:5

    Topics: Adenoviridae; Adenovirus Infections, Human; Aged; Antigens, Viral; Antiviral Agents; Biopsy; Cidofovir; Cytosine; Dexamethasone; Diarrhea; Drug Administration Schedule; Feces; Gastric Mucosa; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Inclusion Bodies, Viral; Intranuclear Inclusion Bodies; Male; Multiple Myeloma; Organophosphonates; Thalidomide; Treatment Outcome

2008